J C Souto|J Fontcuberta - JoVE Visualize

Showing results (41-50 of 130) with videos related to

Pageof 13

Sort By:

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 1998

Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous dosesL Falkon, M Garí, M Barbanoj, et al.

Haemostasis|January 1, 1990

Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitutionM Borrell, L Vila, J Solá, et al.

Scientific Reports|October 24, 2012

High mobility conduction at (110) and (111) LaAlO3/SrTiO3 interfacesG Herranz, F Sánchez, N Dix, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 2, 1998

Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study)J Mateo, A Oliver, M Borrell, et al.

Thrombosis Research|July 1, 1988

Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2J Fontcuberta, E Grau, N Rubio, et al.

Human Mutation|January 1, 1992

Protein C deficiency: identification of a novel two-base pair insertion and two point mutations in exon 7 of the protein C gene in Spanish familiesJ M Soria, J Fontcuberta, M Borrell, et al.

Histology and Histopathology|October 3, 1999

EGF receptor signaling in prostate morphogenesis and tumorigenesisH G Kim, J Kassis, J C Souto, et al.

Annals of Hematology|December 1, 1993

Acquired factor VIII inhibitor preceding chronic lymphocytic leukemiaJ Mateo, R Martino, M Borrell, et al.

Thrombosis and Haemostasis|January 1, 1997

Pharmacokinetics and tolerability of a new low molecular mass heparin (RO-11) in healthy volunteers--a dose-finding study within the therapeutical rangeL Falkon, M Bayés, G Frontera, et al.

Pharmacy World & Science : PWS|September 22, 1995

Adverse reaction to streptokinase with multiple systemic manifestationsI Montserrat, J Altimiras, M Dominguez, et al.

Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:

Pageof 13

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 1998

Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous dosesL Falkon, M Garí, M Barbanoj, et al.

Haemostasis|January 1, 1990

Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitutionM Borrell, L Vila, J Solá, et al.

Scientific Reports|October 24, 2012

High mobility conduction at (110) and (111) LaAlO3/SrTiO3 interfacesG Herranz, F Sánchez, N Dix, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 2, 1998

Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study)J Mateo, A Oliver, M Borrell, et al.

Thrombosis Research|July 1, 1988

Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2J Fontcuberta, E Grau, N Rubio, et al.

Human Mutation|January 1, 1992

Protein C deficiency: identification of a novel two-base pair insertion and two point mutations in exon 7 of the protein C gene in Spanish familiesJ M Soria, J Fontcuberta, M Borrell, et al.

Histology and Histopathology|October 3, 1999

EGF receptor signaling in prostate morphogenesis and tumorigenesisH G Kim, J Kassis, J C Souto, et al.

Annals of Hematology|December 1, 1993

Acquired factor VIII inhibitor preceding chronic lymphocytic leukemiaJ Mateo, R Martino, M Borrell, et al.

Thrombosis and Haemostasis|January 1, 1997

Pharmacokinetics and tolerability of a new low molecular mass heparin (RO-11) in healthy volunteers--a dose-finding study within the therapeutical rangeL Falkon, M Bayés, G Frontera, et al.

Pharmacy World & Science : PWS|September 22, 1995

Adverse reaction to streptokinase with multiple systemic manifestationsI Montserrat, J Altimiras, M Dominguez, et al.

Pageof 13